Myocarditis as an immune-related adverse event with ipilimumab/nivolumab combination therapy for metastatic melanoma (Q89291085)
Jump to navigation
Jump to search
scientific article published on 01 June 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Myocarditis as an immune-related adverse event with ipilimumab/nivolumab combination therapy for metastatic melanoma |
scientific article published on 01 June 2016 |
Statements
Myocarditis as an immune-related adverse event with ipilimumab/nivolumab combination therapy for metastatic melanoma (English)
Arjun Gupta
Franck Hannallah
Thomas Koshy